IDH1 Inhibitor 1
Modify Date: 2025-09-10 23:59:20
IDH1 Inhibitor 1 structure
|
Common Name | IDH1 Inhibitor 1 | ||
|---|---|---|---|---|
| CAS Number | 2234285-81-3 | Molecular Weight | 450.39 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H18F4N6O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IDH1 Inhibitor 1IDH1 Inhibitor 1 is a potent, orally bioavailable, brain-penetrant and selective mutant IDH1 inhibitor with IC50s of 0.021 μM, 0.045 μM, and 2.52 μM for IDH1R132H, IDH1R132C, and IDH1WT, respectively[1]. Anticancer activity[1]. |
| Name | IDH1 Inhibitor 1 |
|---|
| Description | IDH1 Inhibitor 1 is a potent, orally bioavailable, brain-penetrant and selective mutant IDH1 inhibitor with IC50s of 0.021 μM, 0.045 μM, and 2.52 μM for IDH1R132H, IDH1R132C, and IDH1WT, respectively[1]. Anticancer activity[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.021 μM (IDH1R132H), 0.045 μM (IDH1R132C), and 2.52 μM (IDH1WT)[1] |
| In Vitro | IDH1 Inhibitor 1 (Compound 19) inhibits cellular HCT116-IDH1R132H/+ with an IC50 of 0.039 μM[1]. |
| In Vivo | IDH1 Inhibitor 1 (Compound 19) inhibits 2-hydroxyglutarate (2-HG) production in a preclinical xenograft tumor model. IDH1 Inhibitor 1 is also profiled in a patient-derived IDH1 mutant HCT116-IDH1R132H/+ mechanistic xenograft tumor model in mice to evaluate in vivo inhibition of 2-HG production. IDH1 Inhibitor 1, dosed orally at 150 mg/kg, inhibits new 2-HG production[1]. |
| References |
| Molecular Formula | C20H18F4N6O2 |
|---|---|
| Molecular Weight | 450.39 |